Literature DB >> 8725398

Complexity and diversity of mammalian adenylyl cyclases.

R K Sunahara1, C W Dessauer, A G Gilman.   

Abstract

Molecular cloning has permitted identification of several novel isoforms of mammalian adenylyl cyclase; these proteins now comprise a family of at least 10. All of the membrane-bound enzymes are activated by the alpha subunit of G alpha, a receptor-regulated, heterotrimeric guanine nucleotide-binding protein, and by the diterpene forskolin. Certain cyclases are also activated by Ca(2+)-calmodulin, while some are inhibited by the alpha subunits of the three Gi proteins. The discovery of new isoforms has also revealed unanticipated mechanisms of regulation, including activation or inhibition by the G-protein beta gamma subunit complex, inhibition by G(o) alpha, inhibition by Ca2+, and phosphorylation by protein kinases C and A. The effects of activators are often highly synergistic or conditional, suggesting function of these enyzmes as coincidence detectors. The plethora of receptors, G proteins, and adenylyl cyclases permits assembly of very complex signaling systems with a wide variety of integrative characteristics.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8725398     DOI: 10.1146/annurev.pa.36.040196.002333

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  166 in total

1.  Regions on adenylyl cyclase that are necessary for inhibition of activity by beta gamma and G(ialpha) subunits of heterotrimeric G proteins.

Authors:  C Wittpoth; K Scholich; Y Yigzaw; T M Stringfield; T B Patel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

Review 2.  Structural features of heterotrimeric G-protein-coupled receptors and their modulatory proteins.

Authors:  H LeVine
Journal:  Mol Neurobiol       Date:  1999-04       Impact factor: 5.590

3.  Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses.

Authors:  T C Bellamy; J Wood; D A Goodwin; J Garthwaite
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

4.  Altered stress-induced anxiety in adenylyl cyclase type VIII-deficient mice.

Authors:  M L Schaefer; S T Wong; D F Wozniak; L M Muglia; J A Liauw; M Zhuo; A Nardi; R E Hartman; S K Vogt; C E Luedke; D R Storm; L J Muglia
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

5.  Involvement of the cyclic AMP system in the switch from tolerance into supersensitivity to the antinociceptive effect of the opioid sufentanil.

Authors:  M A Hurlé; I Goirigolzarri; E M Valdizán
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 6.  Guanylyl cyclases in unicellular organisms.

Authors:  Jürgen U Linder; Joachim E Schultz
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

7.  Inhibition of adenylyl cyclase by neuronal P2Y receptors.

Authors:  Ursula Unterberger; Eugenia Moskvina; Thomas Scholze; Michael Freissmuth; Stefan Boehm
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

8.  A uniform extracellular stimulus triggers distinct cAMP signals in different compartments of a simple cell.

Authors:  T C Rich; K A Fagan; T E Tse; J Schaack; D M Cooper; J W Karpen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

9.  G-protein βγ subunits in vasorelaxing and anti-endothelinergic effects of calcitonin gene-related peptide.

Authors:  M J P M T Meens; N J A Mattheij; P B van Loenen; L J A Spijkers; P Lemkens; J Nelissen; M G Compeer; A E Alewijnse; J G R De Mey
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

10.  Capacitative Ca2+ entry via Orai1 and stromal interacting molecule 1 (STIM1) regulates adenylyl cyclase type 8.

Authors:  Agnes C L Martin; Debbie Willoughby; Antonio Ciruela; Laura-Jo Ayling; Mario Pagano; Sebastian Wachten; Anders Tengholm; Dermot M F Cooper
Journal:  Mol Pharmacol       Date:  2009-01-26       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.